Vanda Pharmaceuticals, Inc. (NASDAQ:VNDA)
| CAPS Rating |
|
|---|---|
| Open | $5.23 |
| Previous Close | $5.28 |
| Daily Range | $5.08 - $5.26 |
| 52-Week Range | $4.33 - $8.45 |
| Market Cap | $143.05M |
| P/E Ratio | 41.40 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 103,438 |
| Average Daily Volume | 0 |
VNDA
VS S&P 500 (SPY)
How do you think VNDA will perform against the market?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
VNDA Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
VNDA News and Commentary
- You Should Have Seen These Biotech Failures Coming – The Motley Fool
- The Big Bet on Cell Therapeutics – The Motley Fool
- Avoid This Biotech Stock – The Motley Fool
- Bathwater Baby Bottoms – Blog at The Motley Fool
- Another Day, Another Loss For Cell Therapeutics – The Motley Fool
- These 2 Biotechs Are Dangerous Investments – The Motley Fool
- 9 Small Biotechs Near 52-Week Lows – The Motley Fool
- Keep an Eye on Biotech Partners' Earnings – The Motley Fool
- 7 Dirt Cheap Biotech Stocks With Huge Upside – SeekingAlpha
- Why 2011 Could Be a Big Year for Pharmaceutical M&A – SeekingAlpha
- Vanapt: Growth Potential With Fanapt Depot Formulation Now in Trial – SeekingAlpha
- 6 Cash Rich Biotech Stocks With Catalysts – SeekingAlpha
- U.S. Futures Mixed Ahead of Jobless Claims – BloggingStocks
- FDA Insider Trading: Time for an Overhaul? – SeekingAlpha
- Throw the Book at This Guy – The Motley Fool
- Amarin Example Shows Common Sense Is Crucial in Navigating Biotech Sector Volatility – SeekingAlpha
- Vanda Receives Orphan Status for Sleep Drug, but Is It a Money Maker? – SeekingAlpha
- Political Turmoil and Rising Oil Prices: Where to Invest? – SeekingAlpha
- CLDA - BULLS TOAST IF NO TAKEOUT BY TUESDAY – Blog at The Motley Fool
- After the Earnings, What's in the Works For Vanda? – SeekingAlpha
RSS Headlines
Fool UK
